Efficacy of Enhanced External Counterpulsation on Ventricular Function

• Status: Completed
• Trial end date: 2019-03-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the efficacy of Enhanced External Counterpulsation (EECP) therapy on ventricular function in patients with coronary heart disease

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sun Yat-sen University

Criteria

Inclusion Criteria:

• More than 50% stenosis of left main trunk and 3 epicardial coronary arteries and their large branches showed by coronary angiography

• Or history of myocardial infarction

• Or history of prior revascularization

• Signed informed consent to participate in the study

Exclusion Criteria:

• Clinically significant valvular heart disease

• Aortic aneurysm

• Congenital heart disease

• Acute myocarditis

• Arrhythmias significantly interfere with the triggering of the EECP device

• History of cerebral hemorrhage

• Hemorrhagic disease

• Lower limb infection, phlebitis

• Deep venous thrombosis

• Malignant disease

• International normalized ratio (INR) > 2.5

• Uncontrolled hypertension, defined as systolic blood pressure > 180mmHg or diastolic blood pressure > 110mmHg

• Pregnancy